点眼薬市場：タイプ、カテゴリー、エンドユーザー、適応症別-2025-2030年の世界予測

点眼薬市場の2023年の市場規模は12億2,000万米ドルで、2024年には13億1,000万米ドルに達すると予測され、CAGR 7.11％で成長し、2030年には19億8,000万米ドルに達すると予測されています。

点眼薬市場は、乾燥、アレルギー、感染症、緑内障など、さまざまな目の症状を治療するために設計された製品に焦点を当てています。市場の範囲は市販薬から処方薬にまで及び、潤滑、感染症対策、アレルギー緩和、眼圧調整など多様な用途に及ぶ。このような用途の多様性は、慢性疾患の患者や即時の緩和を求める患者といった個々のエンドユーザーや、病院や診療所のような施設関係者に対応するものです。主な成長促進要因としては、加齢性眼障害の発生率増加につながる人口の高齢化、デジタル眼精疲労につながるデジタル画面の普及、ドラッグデリバリーシステムの技術進歩などが挙げられます。最近の進歩、特に防腐剤フリーの製剤や新しいドラッグデリバリー・メカニズムが大きな関心を呼んでいます。医療インフラが整備され、眼の健康に対する意識が高まっている新興国での市場拡大には、潜在的なビジネスチャンスがあります。さらに、遠隔医療とオンライン薬局は、特に遠隔地において、流通と教育のための成長プラットフォームを提供しています。しかし、厳しい規制基準、長期使用に伴う副作用の可能性、価格に敏感なジェネリック医薬品との競合といった課題が市場の成長を妨げています。イノベーションの機会としては、複数の症状に一度に対処する多作用製剤の開発、使いやすい送達システムによる患者のコンプライアンスの改善、AIを活用した個別化治療レジメンなどが挙げられます。バイオアベイラビリティと徐放性製剤に焦点を当てた調査への投資は、競争優位性をもたらす可能性があります。点眼薬市場は、イノベーションと規制や価格設定の課題とのバランスを取りながら、弾力的で成長態勢を整えています。技術の進歩、消費者の安全性の重視、ヘルスケア全体における予防医療への志向の高まりに後押しされ、市場はダイナミックな動きを続けています。これらの要因に対処することが、市場機会を効果的に活用するための中心となります。

市場力学：急速に進化する点眼薬市場の主要市場インサイトを公開

点眼薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人口における眼科疾患および眼感染症の有病率の上昇
  • 世界の老齢人口の増加とそれに伴う眼科手術の増加
  • スクリーン使用時間の増加による子供や若年層の視力問題の増加
• 市場抑制要因
  • 点眼薬の全身的副作用
• 市場機会
  • 点眼薬の新しい研究開発アプローチ
  • 眼科治療薬への投資の増加
• 市場の課題
  • 患者が報告した点眼に関する問題と製品回収

ポーターの5つの力：点眼薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：点眼薬市場における外部からの影響の把握

外部マクロ環境要因は、点眼薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析点眼薬市場における競合情勢の把握

点眼薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス点眼薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、点眼薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨点眼薬市場における成功への道筋を描く

点眼薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人口における眼科疾患および眼感染症の罹患率の上昇
    • 世界中で高齢化人口が増加し、それに伴う眼科手術も増加
    • スクリーンタイムの増加による子供や若年層の視力障害の増加
  • 抑制要因
    • 点眼薬の全身的副作用
  • 機会
    • 点眼薬への新たな研究開発アプローチ
    • 眼科用医薬品への投資増加
  • 課題
    • 点眼薬の点眼に関する患者報告の問題と製品回収
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 点眼薬市場：タイプ別

• 市販の目薬
• 処方目薬

第7章 点眼薬市場：カテゴリ別

• 麻酔点眼薬
• 抗生物質点眼薬
• 膨張点眼薬
• 緑内障点眼薬
• ステロイド点滴

第8章 点眼薬市場：エンドユーザー別

• 眼科クリニック
• 病院
• 医療機関
• 調査機関

第9章 点眼薬市場適応症別

• 加齢黄斑変性症
• 白内障
• 緑内障
• 炎症性疾患
• 屈折異常

第10章 南北アメリカの点眼薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の点眼薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの点眼薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Akorn, Inc.
• Alcon Inc.
• Amneal Pharmaceuticals, Inc.
• Apotex Inc.
• Bausch & Lomb Incorporated
• Catalent, Inc.
• CVS Health
• Duopharma Biotech Berhad
• Geri-Care Pharmaceuticals Corp.
• Honeywell International Inc.
• ImprimisRx
• Johnson & Johnson Services, Inc.
• KC Pharmaceuticals, Inc.
• Mankind Pharma Ltd.
• Mylan N.V.
• Novartis AG
• OCuSOFT, Inc.
• Orimed Pharma Inc.
• Pfizer, Inc.
• Preferred Pharmaceuticals Inc.
• Prestige Consumer Healthcare Inc.
• ROHTO Pharmaceutical Co., Ltd.
• Sager Pharma Kft.
• Santen Pharmaceutical Co., Ltd.
• Similasan Corporation
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Wockhardt

LIST OF FIGURES

• FIGURE 1. OPHTHALMIC DROPS MARKET RESEARCH PROCESS
• FIGURE 2. OPHTHALMIC DROPS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL OPHTHALMIC DROPS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. OPHTHALMIC DROPS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. OPHTHALMIC DROPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. OPHTHALMIC DROPS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL OPHTHALMIC DROPS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. OPHTHALMIC DROPS MARKET DYNAMICS
• TABLE 7. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY OVER-THE-COUNTER EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY PRESCRIPTION EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY ANESTHETIC DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY ANTIBIOTIC DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY DILATION DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY GLAUCOMA DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY STEROID DROPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY EYE CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATARACT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 40. CANADA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 42. CANADA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 62. CHINA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. CHINA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 64. CHINA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. CHINA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 66. INDIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 68. INDIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. INDIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 135. ITALY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ITALY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 137. ITALY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. ITALY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 151. POLAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. POLAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 153. POLAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. POLAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 155. QATAR OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. QATAR OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 157. QATAR OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. QATAR OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
• TABLE 195. OPHTHALMIC DROPS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. OPHTHALMIC DROPS MARKET, FPNV POSITIONING MATRIX, 2023

The Ophthalmic Drops Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.31 billion in 2024, and is projected to grow at a CAGR of 7.11%, to USD 1.98 billion by 2030.

The ophthalmic drops market focuses on products designed for treating a variety of eye conditions such as dryness, allergies, infections, and glaucoma. The market's scope extends from over-the-counter formulations to prescription medications and spans diverse applications including lubrication, infection control, allergy relief, and intraocular pressure regulation. This diversity in application caters to individual end-users, such as patients with chronic conditions or those seeking immediate relief, and institutional stakeholders like hospitals and clinics. Key growth drivers include an aging population leading to an increased incidence of age-related eye disorders, widespread digital screen usage leading to digital eye strain, and technological advancements in drug delivery systems. Recent advancements, particularly in preservative-free formulations and novel drug delivery mechanisms, are generating considerable interest. Potential opportunities lie in expanding the market in emerging economies with growing healthcare infrastructure and increased awareness about ocular health. Furthermore, telemedicine and online pharmacies present a growing platform for distribution and education, especially in remote regions. However, market growth is hindered by challenges such as stringent regulatory standards, potential side effects associated with long-term use, and significant competition from generic products that drive price sensitivity. Innovation opportunities include developing multi-action formulations that address several symptoms at once, improving patient compliance through user-friendly delivery systems, and leveraging AI for personalized treatment regimens. Investment in research focused on bioavailability and extended-release formulations could offer competitive advantages. The ophthalmic drops market is resilient and poised for growth, balancing innovation with regulatory and pricing challenges. It remains dynamic, driven by technological advancements, an emphasis on consumer safety, and an increasing inclination toward preventive care within the healthcare continuum. Addressing these factors will be central to leveraging market opportunities effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Drops Market

The Ophthalmic Drops Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising Prevalence of Ophthalmic Disease and Eye Infection among the Population
  • Growing Old Age Population and Associated Eye-Surgeries Worldwide
  • Growth of Vision Problems in Kids and Younger Population due to More Screen Time
• Market Restraints
  • Systemic Side Effects of Ophthalmic Drops
• Market Opportunities
  • New Research & Development Approach to Ophthalmic Drops
  • Increase in Investment for Ophthalmology Medication
• Market Challenges
  • Patient-Reported Problems Related to Eye Drop Instillation and Product Recall

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Drops Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Drops Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Drops Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Drops Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Drops Market

A detailed market share analysis in the Ophthalmic Drops Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Drops Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Drops Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmic Drops Market

A strategic analysis of the Ophthalmic Drops Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Drops Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Akorn, Inc., Alcon Inc., Amneal Pharmaceuticals, Inc., Apotex Inc., Bausch & Lomb Incorporated, Catalent, Inc., CVS Health, Duopharma Biotech Berhad, Geri-Care Pharmaceuticals Corp., Honeywell International Inc., ImprimisRx, Johnson & Johnson Services, Inc., KC Pharmaceuticals, Inc., Mankind Pharma Ltd., Mylan N.V., Novartis AG, OCuSOFT, Inc., Orimed Pharma Inc., Pfizer, Inc., Preferred Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., ROHTO Pharmaceutical Co., Ltd., Sager Pharma Kft., Santen Pharmaceutical Co., Ltd., Similasan Corporation, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Wockhardt.

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Drops Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Over-the-counter Eye Drops and Prescription Eye Drops.
• Based on Category, market is studied across Anesthetic Drops, Antibiotic Drops, Dilation Drops, Glaucoma Drops, and Steroid Drops.
• Based on End User, market is studied across Eye Clinic, Hospitals, Medical Institutes, and Research Organizations.
• Based on Indications, market is studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Prevalence of Ophthalmic Disease and Eye Infection among the Population
    • 5.1.1.2. Growing Old Age Population and Associated Eye-Surgeries Worldwide
    • 5.1.1.3. Growth of Vision Problems in Kids and Younger Population due to More Screen Time
  • 5.1.2. Restraints
    • 5.1.2.1. Systemic Side Effects of Ophthalmic Drops
  • 5.1.3. Opportunities
    • 5.1.3.1. New Research & Development Approach to Ophthalmic Drops
    • 5.1.3.2. Increase in Investment for Ophthalmology Medication
  • 5.1.4. Challenges
    • 5.1.4.1. Patient-Reported Problems Related to Eye Drop Instillation and Product Recall
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Ophthalmic Drops Market, by Type

• 6.1. Introduction
• 6.2. Over-the-counter Eye Drops
• 6.3. Prescription Eye Drops

7. Ophthalmic Drops Market, by Category

• 7.1. Introduction
• 7.2. Anesthetic Drops
• 7.3. Antibiotic Drops
• 7.4. Dilation Drops
• 7.5. Glaucoma Drops
• 7.6. Steroid Drops

8. Ophthalmic Drops Market, by End User

• 8.1. Introduction
• 8.2. Eye Clinic
• 8.3. Hospitals
• 8.4. Medical Institutes
• 8.5. Research Organizations

9. Ophthalmic Drops Market, by Indications

• 9.1. Introduction
• 9.2. Age-Related Macular Degeneration
• 9.3. Cataract
• 9.4. Glaucoma
• 9.5. Inflammatory Diseases
• 9.6. Refractive Disorders

10. Americas Ophthalmic Drops Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Ophthalmic Drops Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Ophthalmic Drops Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Akorn, Inc.
• 3. Alcon Inc.
• 4. Amneal Pharmaceuticals, Inc.
• 5. Apotex Inc.
• 6. Bausch & Lomb Incorporated
• 7. Catalent, Inc.
• 8. CVS Health
• 9. Duopharma Biotech Berhad
• 10. Geri-Care Pharmaceuticals Corp.
• 11. Honeywell International Inc.
• 12. ImprimisRx
• 13. Johnson & Johnson Services, Inc.
• 14. KC Pharmaceuticals, Inc.
• 15. Mankind Pharma Ltd.
• 16. Mylan N.V.
• 17. Novartis AG
• 18. OCuSOFT, Inc.
• 19. Orimed Pharma Inc.
• 20. Pfizer, Inc.
• 21. Preferred Pharmaceuticals Inc.
• 22. Prestige Consumer Healthcare Inc.
• 23. ROHTO Pharmaceutical Co., Ltd.
• 24. Sager Pharma Kft.
• 25. Santen Pharmaceutical Co., Ltd.
• 26. Similasan Corporation
• 27. Sun Pharmaceutical Industries Ltd.
• 28. Teva Pharmaceutical Industries Ltd.
• 29. Wockhardt